Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ

Molecular Nutrition and Food Research

Volumn 58, Issue 4, 2014, Pages 718-726

  Sakamoto, Yuri ^a   Naka, Ayano ^a   Ohara, Nozomi ^a   Kondo, Kazuo ^a   Iida, Kaoruko ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Adipokines; Daidzein; Diet induced obesity; Inflammation; Peroxisome proliferator activated receptor

Indexed keywords

ADIPOCYTOKINE; DAIDZEIN; ISOFLAVONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

3T3 CELL LINE; ADIPOGENESIS; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DIET SUPPLEMENTATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PATHOPHYSIOLOGY; WEIGHT GAIN;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOKINES; ANIMALS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; ISOFLAVONES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PPAR GAMMA; WEIGHT GAIN;

EID: 84897100850     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300482     Document Type: Article

References (44)

1. Setchell, K. D., Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998, 68, 1333S-1346S.
2. Setchell, K. D., Cassidy, A., Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 1999, 129, 758S-767S.
3. Friedman, M., Brandon, D. L., Nutritional and health benefits of soy proteins. J. Agric. Food Chem. 2001, 49, 1069-1086.
4. Bhathena, S. J., Velasquez, M. T., Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 2002, 76, 1191-1201.
5. Mezei, O., Banz, W. J., Steger, R. W., Peluso, M. R. et al., Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J. Nutr. 2003, 133, 1238-1243.
6. Ronis, M. J., Chen, Y., Badeaux, J., Badger, T. M., Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J. Nutr. 2009, 139, 1431-1438.
7. Trayhurn, P., Wood, I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92, 347-355.
8. Greenberg, A. S., Obin, M. S., Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 2006, 83, 461S-465S.
9. Schenk, S., Saberi, M., Olefsky, J. M., Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118, 2992-3002.
10. Neels, J. G., Olefsky, J. M., Inflamed fat: what starts the fire? J. Clin. Invest. 2006, 116, 33-35.
11. Di Gregorio, G. B., Yao-Borengasser, A., Rasouli, N., Varma, V. et al., Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54, 2305-2313.
12. Jiang, C., Ting, A. T., Seed, B., PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391, 82-86.
13. Lumeng, C. N., Bodzin, J. L., Saltiel, A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117, 175-184.
14. Ramirez-Zacarias, J. L., Castro-Munozledo, F., Kuri-Harcuch, W., Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992, 97, 493-497.
15. Sharma, A. M., Staels, B., Review: peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 2007, 92, 386-395.
16. Choi, M. S., Jung, U. J., Yeo, J., Kim, M. J. et al., Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 2008, 24, 74-81.
17. Kim, M. H., Park, J. S., Jung, J. W., Byun, K. W. et al., Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. (Lond.) 2011, 35, 1019-1030.
18. Adams, M., Montague, C. T., Prins, J. B., Holder, J. C. et al., Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 1997, 100, 3149-3153.
19. Okuno, A., Tamemoto, H., Tobe, K., Ueki, K. et al., Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998, 101, 1354-1361.
20. Gustafson, B., Jack, M. M., Cushman, S. W., Smith, U., Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochem. Biophys. Res. Commun. 2003, 308, 933-939.
21. Dang, Z. C., Audinot, V., Papapoulos, S. E., Boutin, J. A. et al., Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 2003, 278, 962-967.
22. Dang, Z., Lowik, C. W., The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J. Bone Miner. Res. 2004, 19, 853-861.
23. Cho, K. W., Lee, O. H., Banz, W. J., Moustaid-Moussa, N. et al., Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J. Nutr. Biochem. 2010, 21, 841-847.
24. Harmon, A. W., Harp, J. B., Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J. Physiol. Cell Physiol. 2001, 280, C807-C813.
25. Hwang, J. T., Park, I. J., Shin, J. I., Lee, Y. K. et al., Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2005, 338, 694-699.
26. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y. et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
27. Berg, A. H., Combs, T. P., Du, X., Brownlee, M. et al., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7, 947-953.
28. Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T. et al., Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52, 1655-1663.
29. Tsuchida, A., Yamauchi, T., Takekawa, S., Hada, Y. et al., Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005, 54, 3358-3370.
30. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M. et al., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 2007, 13, 332-339.
31. Pearson, S. L., Cawthorne, M. A., Clapham, J. C., Dunmore, S. J. et al., The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats. Biochem. Biophys. Res. Commun. 1996, 229, 752-757.
32. Yamauchi, T., Kamon, J., Waki, H., Murakami, K. et al., The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 2001, 276, 41245-41254.
33. Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A. et al., Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43, 1498-1506.
34. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
35. Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
36. Cancello, R., Henegar, C., Viguerie, N., Taleb, S. et al., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54, 2277-2286.
37. Suganami, T., Nishida, J., Ogawa, Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2062-2068.
38. Kanda, H., Tateya, S., Tamori, Y., Kotani, K. et al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116, 1494-1505.
39. Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M. et al., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 2006, 281, 26602-26614.
40. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J. et al., CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 2006, 116, 115-124.
41. Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T. et al., Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004, 110, 1564-1571.
42. Li, P., Lu, M., Nguyen, M. T., Bae, E. J. et al., Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 2010, 285, 15333-15345.
43. Adlercreutz, H., Markkanen, H., Watanabe, S., Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993, 342, 1209-1210.
44. King, R. A., Bursill, D. B., Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 1998, 67, 867-872.